ACTIVE

EsoBiotec

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result7,7 M €+212,5 %over 1 year

Gross margin26,8 M €+3 614,5 %over 1 year

Equity12,4 M €+726,0 %over 1 year

Workforce9,4 ETP-11,3 %over 1 year

Identity

Source · BCE/KBO

EsoBiotec is a Public limited company incorporated in 2020. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Mont-Saint-Guibert. It employs on average 9,4 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0756.885.159
Incorporation: 22/10/2020
Legal form: Public limited company
Registered office: Rue André Dumont 5
1435 Mont-Saint-Guibert · WallonieSee on map
Contributed capital: 15 432 208,13 €
Latest accounts: 31/12/2025
Average workforce: 9,4 ETP

Activities (NACE)

72109Research and experimental development on natural sciences and engineering· main 72190Other research and experimental development on natural sciences and engineering

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 5 filings

Trend over 5 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	26,8 M €	+3615%	-761,8 k €	-257%	483,7 k €	-77.8%	2,2 M €	+2543%	82,3 k €
EBITDA	18 M €	+1112%	-1,8 M €	-82.3%	-976,2 k €	-166%	1,5 M €	+919%	-180,5 k €
Operating result	11,1 M €	+255%	-7,2 M €	-162%	-2,7 M €	-158%	-1,1 M €	-441%	-196,3 k €
Net result	7,7 M €	+212%	-6,9 M €	-157%	-2,7 M €	-167%	-1 M €	-406%	-198,3 k €
Balance sheet
Equity	12,4 M €	+726%	1,5 M €	-36.8%	2,4 M €	-52.9%	5,1 M €	+119%	2,3 M €
Total assets	16,5 M €	+283%	4,3 M €	-34.0%	6,5 M €	-10.7%	7,3 M €	+53.8%	4,7 M €
Cash	113,2 k €	-91.3%	1,3 M €	-6.8%	1,4 M €	-66.1%	4,1 M €	+30.5%	3,2 M €
Debts	4 M €	+44.9%	2,8 M €	-10.8%	3,1 M €	+172%	1,2 M €	+151%	459,6 k €
Other
Workforce	9,4 ETP	-11.3%	10,6 ETP		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ANGELA THOMPSON	Director19/05/2025 → 25/06/2031
CARSTEN LINNEMANN	Director19/05/2025 → 25/06/2031
JEAN-PIERRE LATERE DWAN'ISA	Director20/08/2024 → 20/08/2030Mandate2023 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Emmanuel Lacroix	Mandate2021 accounts
ERICA WHITTAKER	Mandate2023 accounts
FONDS DE CAPITAL A RISQUE 20200667.964.566	Mandate2023 accounts
KNCL0645.689.309Represented by JEAN-PIERRE LATERE DWAN'ISA	Mandate2023 accounts

Other companies at this address

Rue André Dumont 5 1435 Mont-Saint-Guibert

Company	CBE no.
3D-SIDE● Active	0597.918.094
Centre de Coordination et de Référence pour le dépistage des cancers● Active	0478.939.973

Full financial information

Source · NBB

	2025	2024	2023	2022	2021
Type of account	Abridged model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	20/10/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021
Length of the financial year	12 months	12 months	12 months	12 months	15 months
Filing date	07/07/2026	08/07/2025	27/06/2024	29/06/2023	05/07/2022
General meeting	30/06/2026	25/06/2025	26/06/2024	28/06/2023	29/06/2022
Currency of the financial year	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/06/2026	07/07/2026	French	PDF
Abridged model	31/12/2024	25/06/2025	08/07/2025	French	PDF
Micro model	31/12/2023	26/06/2024	27/06/2024	French	PDF
Micro model	31/12/2022	28/06/2023	29/06/2023	French	PDF
Micro model	31/12/2021	29/06/2022	05/07/2022	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ANGELA THOMPSON	Director19/05/2025 → 25/06/2031
CARSTEN LINNEMANN	Director19/05/2025 → 25/06/2031
JEAN-PIERRE LATERE DWAN'ISA	Director20/08/2024 → 20/08/2030Mandate2023 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Emmanuel Lacroix	Mandate2021 accounts
ERICA WHITTAKER	Mandate2023 accounts
FONDS DE CAPITAL A RISQUE 20200667.964.566	Mandate2023 accounts
KNCL0645.689.309Represented by JEAN-PIERRE LATERE DWAN'ISA	Mandate2023 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates27/07/2026
Nomination d'un administrateur
PDF
Mandates15/07/2026
Démission d'un administrateur et délégué à la gestion journalière
PDF
Mandates27/10/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates25/07/2025
DEMISSIONS, NOMINATIONS
PDF
Other28/05/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Capital / shares23/05/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Capital / shares26/02/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Mandates29/08/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings5 filings

Mandates

CARSTEN LINNEMANN

ANGELA THOMPSON

JEAN-PIERRE LATERE DWAN'ISA

KNCL

FONDS DE CAPITAL A RISQUE 2020

ERICA WHITTAKER

Emmanuel Lacroix

MICHEL BRIEJER

PAUL RENNERT

202020212022202320242025202620272028202920302031

EsoBiotec

Rue André Dumont 5, 1435 Mont-Saint-Guibert

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue André Dumont 5, 1435 Mont-Saint-GuibertCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00275331
Rue Adrienne Bolland 8, 6041 Gosselies	accounts 2021	Accounts 2021 · 2022-20151103

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
EsoBiotecCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00275331

Events

2025
Annual accounts 20257,7 M €↑
2024
Annual accounts 2024-6,9 M €↓
2023
Annual accounts 2023-2,7 M €↓
2022
Annual accounts 2022-1 M €↓
2021
Annual accounts 2021-198,3 k €
22/10/2020
IncorporationPublic limited company

EsoBiotec

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events